Dr. Reddy's Wants Teva's Coreg Claims Bounced
By Erin Marie Daly ( September 4, 2007, 12:00 AM EDT) -- Dr. Reddy's Laboratories Inc. has fought back against Teva Pharmaceutical Industries Ltd. in the battle over GlaxoSmithKline Inc.'s drug Coreg, saying a lawsuit that seeks to bar Dr. Reddy's from marketing a generic version of the congestive heart failure treatment should be scrapped because all claims of the asserted patents are invalid....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.